CVRx
CVRX | NASDAQ
$0.61
$0.00 (+0.43%)
At close: Nov 16, 2026, 4:00 PM ET
$0.67
+$0.06 (+9.84%)
After-hours:
Nov 16, 2026, 7:30 PM ET
CVRx Company Profile
Company profile explainedCompany Profile
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.
Key Executives
| Name | Position |
|---|---|
| Kevin Hykes | President, Chief Executive Officer & Director |
| Brent Binkowski | Chief Operating Officer |
| Bonnie Handke | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics |
| Gregory Morrison | Chief Human Resources Officer |
| Jared Oasheim | Consultant |
| Matt Klein | Vice President, Legal & Compliance Officer |
| Patrick Lyon | Vice President of Marketing |
| Paul Verrastro | Interim Head of Sales |
| Philip Adamson | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 02, 2026 | SC 13D/A | [Amend] Filing |
| Sep 21, 2026 | 8-K | Current Report |
| Aug 24, 2026 | SC 13D | Filing |
| Aug 14, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 13, 2026 | 4 | Filing |
| Aug 13, 2026 | 4 | Filing |
| Aug 11, 2026 | 8-K | Current Report |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jun 09, 2026 | 8-K | Current Report |
CVRx
| Country | United States |
| IPO Date | Jun 30, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 223 |
| CEO | Kevin Hykes |
Contact Details
9201 West Broadway Avenue Minneapolis,
Minnesota 55445 United States
Stock Details
| Ticker Symbol | CVRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001235912 |
| CUSIP Number | 126638105 |
| ISIN Number | US1266381052 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove CVRX